Background: First dose hypotension after the administration of an angiotensin-converting
enzyme inhibitor in patients with acute myocardial infarction is one of the most important …

OBJECTIVE To verify the efficacy of the combination of captopril (75 mg day) and losartan
(25 mg/day) in early postinfarction phases of reperfused anterior acute myocardial infarction …

Background Many trials have proved the benefits of early systematic treatment with
angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction (AMI) …

Angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce both morbidity
and mortality in patients with chronic heart failure1 and in high-risk patients after acute …

Aims To evaluate initial blood pressure effects of the angiotensin II antagonist losartan (L)
immediately after switching from an ACE inhibitor (captopril, C). Methods Two‐phase …

Objective Our purpose was to compare the blood pressure response to short-term treatment
with captopril or trandolapril in patients with left ventricular (LV) dysfunction after acute …

Background ACE inhibitors attenuate the detrimental effects of angiotensin II, and improve
survival and reduce morbidity in patients with acute myocardial infarction and evidence of …

Beta-blockers, angiotensin-converting–enzyme (ACE) inhibitors, and aldosterone
antagonists have been shown to reduce the overall risk of death as well as the risk of major …

Aim of study: Angiotensin‐converting enzyme (ACE) inhibitors prolong life, lower the
progression of heart failure, and decrease the need for hospitalizations in patients after …

Abstract< A positive history of arterial hypertension (HBP) is present in as many as 30% of
patients with acute myocardial infarction (AMI) and their clinical outcome could be greatly …